Skip to main content
Explore URMC

William B. Tabayoyong, M.D., Ph.D.

Contact Information

Phone Numbers

Appointment: (585) 275-2838

Fax: (585) 273-1068

URMFGA member of the University of Rochester Medical Faculty Group

groupAn Accountable Health Partner

assignmentAccepting New Patients

Faculty Appointments

Patient Care Settings

Surgery, Urology


Dr. Tabayoyong is a Urologic Oncologist who specializes in both minimally invasive urologic oncology (robotic surgery of the bladder, prostate, and kidney cancers) and advanced open pelvic and retroperitoneal cancer surgery. Dr. Tabayoyong has clinical expertise in all aspects of general urology with special emphasis on the following: Bladder Cancer, Prostate Cancer, Kidney Cancer, Testicular Cancer, Penile Cancer.

Dr. Tabayoyong received his medical degree and PhD in Immunology at the University of Iowa’s Carver College of Medicine Medical Scientist Training Program at the University of Iowa in Iowa City, Iowa in 2011. He completed his urology residency at Case Western Reserve University School of Medicine in Cleveland, Ohio, in 2017. Following residency, he completed a two-year Society of Urologic Oncology fellowship at the University of Texas, MD Anderson Cancer Center in Houston, Texas, in 2019. His research interest is in Immunotherapy for urologic cancers, with primary focus on bladder cancer.



MD | University Of Iowa Roy J & Lucille A Carver College Of Medicine

Post-doctoral Training & Residency

07/01/2017 - 06/30/2019
Fellowship in Urologic Oncology at University of Texas MD Anderson Cancer Center

07/01/2012 - 06/30/2017
Residency in Urology at University Hospitals Case Medical Center

07/01/2011 - 06/30/2012
Internship in Surgery (General Surgery) at University Hospitals Case Medical Center

VIEW ALL expand_more

Clinical Trials

A Randomized Phase III Double-Blind Clinical Trial Evaluating the Effect of Immune-Enhancing Nutrition on Radical Cystectomy Outcome (S1600)

Lead Researcher: William B Tabayoyong

This phase III trial studies how well nutrition therapy works in improving immune system in patients with bladder cancer that can be removed by surgery. Improving nutrition before and after surgery may reduce the infections and other problems that sometimes occur after surgery.

View Study Details


Journal Articles

Matulay JT, Tabayoyong W, Duplisea JJ, Chang C, Daneshmand S, Gore JL, Holzbeierlein JM, Karsh LI, Kim SP, Konety BR, Li R, McKiernan JM, Messing EM, Steinberg GD, Williams SB, Kamat AM. "Variability in adherence to guidelines based management of nonmuscle invasive bladder cancer among Society of Urologic Oncology (SUO) members." Urologic oncology.. 2020 May 16; Epub 2020 May 16.

Li R, Metcalfe MJ, Tabayoyong WB, Guo CC, Nogueras González GM, Navai N, Grossman HB, Dinney CP, Kamat AM. "Using Grade of Recurrent Tumor to Guide Further Therapy While on Bacillus Calmette-Guerin: Low-grade Recurrences Are not Benign." European urology oncology.. 2019 May; 2(3):286-293. Epub 2018 Sep 10.

Li R, Tabayoyong WB, Guo CC, González GMN, Navai N, Grossman HB, Dinney CP, Kamat AM. "Prognostic Implication of the United States Food and Drug Administration-defined BCG-unresponsive Disease." European urology.. 2019 Jan; 75(1):8-10. Epub 2018 Oct 06.

Books & Chapters

Chapter Title: Radical Prostatectomy
Book Title: Netter's Surgical Anatomy and Approaches
Author List: Conor P. Delaney
Published By: Elsevier 2014 in Philadelphia, PA




William Tabayoyong, MD, UR Medicine Urology